ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mannose-Binding Lectin 2 as a Potential Therapeutic Target for Hepatocellular Carcinoma: Multi-Omics Analysis and Experimental Validation

Liao, Hangyu; Yang, Jun; Xu, Yuyan; Xie, Juncheng; Li, Ke; Chen, Kunling; Pei, Jingyuan; Luo, Qiong*; Pan, Mingxin*南方医科大学
Cancers2023-10DOI: 10.3390/cancers15194900
5阅读
引用收藏
分享

摘要

Simple Summary This study focuses on understanding the role of mannose-binding lectin 2 (MBL2) in hepatocellular carcinoma (HCC) and its potential as a target for therapy. Our objective was to investigate the influence of MBL2 on the proliferation and metastasis of hepatocellular carcinoma using integrated multi-omics analysis and experimental validation, with a specific emphasis on MBL2-related microRNAs. The results showed that low levels of MBL2 were associated with poor prognosis in HCC patients. We also found that increasing MBL2 levels could directly inhibit HCC cell growth and spread. Furthermore, miR-34c-3p was found to be a regulator of MBL2 expression. These findings provide new insights into the development of HCC and suggest that increasing MBL2 levels could be a potential strategy for HCC treatment.Abstract Mannose-binding lectin 2 (MBL2), a member of the multimeric lectin family, is crucial in immune regulation and tumor development. MBL2 gene polymorphisms are associated with the risk and prognosis of various tumors, including hepatocellular carcinoma (HCC). Its functional role in HCC remains largely unclear. In this study, we aimed to identify whether MBL2 is a key regulator and a potential therapeutic target for HCC. A bioinformatics analysis revealed close relationships among MBL2 downregulation, the tumor-associated proliferation and metastasis pathway, and tumor immunosuppressive microenvironments. Lower expression of MBL2 in HCC patients was linked to an unfavorable prognosis. A cell counting kit-8 assay, colony formation assay, transwell migration assay, and wound healing assay further confirmed that the overexpression of MBL2 could directly inhibit the proliferation and metastasis of HCC. Moreover, MBL2 expression was regulated by miR-34c-3p, as confirmed by the dual-luciferase reporter assay, thereby demonstrating tumor progression in HCC cells. Thus, our study offers the first comprehensive confirmation of the role of MBL2 in the development of HCC through multi-omics analysis and experimental validation. Furthermore, miR-34c-3p was found to be an upstream mechanism of the downregulation of MBL2 expression and could be a promising therapeutic target, expanding treatment options for patients with HCC.

学科与关键词

关键词
hepatocellular carcinomamannose-binding lectin 2tumor microenvironmentmiR-34c-3pimmune regulation
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancers
发表日期
2023-10
卷期
第 15 卷, 第 19 期
页码
4900
DOI
10.3390/cancers15194900
成果收录
SCIE
资助标注
We sincerely acknowledge the TCGA, ICGC, ANTE, and GEO databases for providing their platforms and the contributors for uploading meaningful datasets.

作者

  • L

    Liao, Hangyu (第一作者)

    southern med univ

  • Y

    Yang, Jun

    southern med univ

查看全部 9 位作者收起作者
  • X

    Xu, Yuyan

    southern med univ

  • X

    Xie, Juncheng

    southern med univ

  • L

    Li, Ke

    southern med univ · first hosp changsha

  • C

    Chen, Kunling

    southern med univ

  • P

    Pei, Jingyuan

    southern med univ

  • L

    Luo, Qiong (通讯)

    southern med univ

  • P

    Pan, Mingxin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417